Undervalued Robotics Stock Alert

Why is an AI robotics company with $3.2M in revenue valued at just $50M while competitors with less revenue sit at $448M?

NBIX
Neurocrine Biosciences, Inc
NASDAQ
134.02
Open 134.11 Prev Close 134.11
High 134.11 Low 134.02
Volume 2 Volume (Avg) 1,169
52 Week High 157.98 52 Week Low 84.23
Market Cap 13.3B PE Ratio 45.44

About Neurocrine Biosciences, Inc

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia. Its product candidates in clinical development include valbenazine to treat dyskinetic cerebral palsy and schizophrenia; NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia; NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Mitsubishi Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

General

NameNeurocrine Biosciences, Inc
TickerNBIX
ExchangeNASDAQ
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees1,800

Highlights

Analyst Target161.30
Market Cap13,263,400,000
PE Ratio45.44
PEG Ratio0.27
EBITDA529,900,000

Share Stats

Shares Outstanding99,000,000
Shares Float95,470,000
Shares Short3,530,000
Insider Holdings106%
Institution Holdings98.66%

Highlights

Analyst Target161.30
Market Cap13,263,400,000
PE Ratio45.44
PEG Ratio0.27
EBITDA529,900,000

Valuation

Trailing PE45.46
Forward PE25.51
Price/Sales (Trailing 12 Mt.)5.50
Price/Book (Most Recent Quarter)5.12

Earnings

Most Popular

Trump's 'Big, Beautiful Bill' Offers Seniors A $6,000 'Bonus' Tax Deduction: Here's How You Qualify For The Benefit

Trump's Big, Beautiful Bill offers a $6,000 senior bonus deduction from 2025-28. Couples can save $12,000. Retirees with incomes up to $75,000 benefit most.

Elon Musk Once Revealed How He Comes Up With 'Crazy Ideas' — And Gets Them Off The Ground Even When Funding Is Scarce

Elon Musk once explained that he turns ambitious ideas into reality by starting with low-cost software ventures, using first principles thinking, and combining insights across industries—even without major funding.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

Australian prime minister indulges in panda diplomacy as state visit in China nears end

BEIJING (AP) — Australian Prime Minister Anthony Albanese has toured a panda breeding facility in the final stages of an extended state visit that has cast China as a fellow champion of a global fair trade system .

Trump keeps saying the GOP mega bill will eliminate taxes on Social Security. It does not

WASHINGTON (AP) — President keeps saying that Republicans' mega legislation will eliminate taxes on federal benefits.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Li Auto's Strong Q2 Deliveries Mask June's Steep Decline

Li Auto (LI) reported 36,279 vehicles delivered in June 2025, down 24.1% YoY. Q2 saw a 2.4% YoY increase with 111,074 vehicles delivered. Li's cumulative deliveries since inception reached 1,337,810.

The Robotics Underdog Ready to Run - Ad

An AI robotics company cutting crime by 46% and scaling fast-yet its valuation lags behind peers.

Elon's Greatest Invention... Hidden in South Memphis? - Ad

In South Memphis, I uncovered what could be Elon Musk's biggest invention yet. It's so secretive, rivals are flying drones to spy on it. If you're serious about investing in AI, now's the time to see what's really going on inside those walls.

Trump's 'Big, Beautiful Bill' Hands $5 Billion Win To Big Pharma: Report

Trump's $3.3 trillion domestic agenda bill, passed by the House on Thursday, includes a significant victory for pharmaceutical companies .

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Warren Buffett Skips Big Banks Like JPMorgan and Wells Fargo, Bets $459 Million On This One Asset

Warren Buffett has shifted his investment strategy, investing $459 million in Sirius XM after selling his stakes in Bank of America, JPMorgan Chase, and Wells Fargo.

Copper's Spiking - And This Junior Has the Grades to Match - Ad

Copper is climbing again - and this time, it looks tariff-proof. A $31M junior just posted nearly 1B lbs of copper equivalent. With insiders and institutions piling in, this could be the next breakout.

Tesla debuts in India with upscale showroom launch in Mumbai

NEW DELHI (AP) — opened its first showroom in on Tuesday, marking the electric vehicle maker’s long-anticipated debut in the world’s third-biggest automotive market.

FDA Submission Expected This Summer - Invest Before It Happens - Ad

This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.

After years of tough rules on liquids and footwear, US air travel may be on the cusp of a new era

NEW YORK (AP) — When limits on liquids were introduced at TSA checkpoints across the country in 2006, bins overflowed with bottled water, toothpaste, shaving cream and so much more. Nearly two decades later, travelers are much more accustomed to the “3-1-1” regulations" governing the size of the liquids they're flying with, but scenes of passengers guzzling a beverage before putting their bags through the screening machines are still common.

Nvidia $1,499 Gaming GPU From 2020 Nails Ming Dynasty Vase Price Within 30% of Final Sale: Here's How

Researchers used deep learning on centuries of kiln styles and auction data to accurately predict Chinese ceramics' prices, using only a gaming card.

A Robotics Leader in Disguise - Ad

Forget the hype. Real revenue, growing contracts, and a low float make this stock a hidden gem in the robotics space.

AstraZeneca In $15 Billion Talks For Drug That Could Upend Lung Cancer Treatment

AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.

Inside the high-stakes battle to win a New York City casino license

NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.

Back This Medical AI Tech - Ad

You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.

ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday

ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.

US Stocks Likely To Open Lower After A Week Of Records: Tesla In Focus As Elon Musk Announces America Party

U.S. stock futures declined on Monday after scaling fresh records in the previous truncated week. Futures of benchmarks were trading lower.

Undervalued Robotics Stock Alert - Ad

Why is an AI robotics company with $3.2M in revenue valued at just $50M while competitors with less revenue sit at $448M?

ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?

Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.

Seven & i Crashes 9% After Couche-Tard Yanks $47 Billion Takeover Bid, Slams 'Lack of Good Faith' Talks — Tokyo Retail Giant Calls Move 'Unilateral'

Seven & i Holdings shares tumbled 9% on Thursday on the Tokyo exchange to a low of 2,000 Japanese Yen ($13.50) after Canada's Alimentation Couche-Tard withdrew its $47 billion takeover bid, citing "persistent lack of good faith engagement." Trading resumed at 10:16 a.m. local time following a halt.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

South Korea's top court upholds acquittal of Samsung's Lee over contentious 2015 merger

SEOUL, South Korea (AP) — South Korea’s top court Thursday upheld the acquittal of Samsung Electronics Chairman Lee Jae-yong on financial , ending years of legal disputes over the 2015 merger between Samsung affiliates that solidified his control over the company.

States brace for impact as Trump's big bill nears completion in Congress

JEFFERSON CITY, Mo. (AP) — President Donald Trump’s and reduce federal spending on some social safety net programs could have large implications for states, but for many it’s too late to do much about it this year.

Robotics Meets Public Safety Innovation - Ad

Advanced security robots, real-world impact, and a valuation gap too big to ignore. This robotics stock is one to watch.

Jim Cramer Made 'FAANG' Popular, Now He Says There's A New Acronym To Describe These Retail Favorite Stocks — 'PARC'

Renowned TV host Jim Cramer is stirring chatter on X with another buzzworthy "meme stock" acronym, aimed at a new group of retail-favorite stocks that are defying gravity.

Trump says he's not planning to extend a pause on global tariffs beyond July 9

WASHINGTON (AP) — President Donald Trump says he is not planning to extend on most nations beyond July 9, when the negotiating period he set would expire, and his administration will notify countries that the trade penalties will take effect unless there are

The Robotics Underdog Ready to Run - Ad

An AI robotics company cutting crime by 46% and scaling fast-yet its valuation lags behind peers.

Feihe Struggles Amid China's Dairy Oversupply And Falling Birth Rates

Declining birth rates and China's slowing economy are taking a toll on the company and its peers as they grapple with oversupply and asset impairments on excess inventory

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service